Mechanisms of neuronal death in synucleinopathy

Journal of Biomedicine and Biotechnology

Volumn 2006, Issue , 2006, Pages

  Takeda, Atsushi ^a   Hasegawa, Takafumi ^a   Matsuzaki Kobayashi, Michiko ^a   Sugeno, Naoto ^a   Kikuchi, Akio ^a   Itoyama, Yasuto ^a   Furukawa, Katsutoshi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; CATECHOL DERIVATIVE; MUTANT PROTEIN; OLIGOMER; QUINONE DERIVATIVE;

CELL MEMBRANE; CELL PROTECTION; CYTOTOXICITY; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; NERVE CELL NECROSIS; NERVE DEGENERATION; PARKINSON DISEASE; PATHOGENESIS; PROTEIN AGGREGATION; SHORT SURVEY; SHY DRAGER SYNDROME; SYNUCLEINOPATHY;

EID: 33746800125     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/JBB/2006/19365     Document Type: Short Survey

References (39)

1. J L Eriksen T M Dawson D W Dickson L Petrucelli Caught in the act: α-synuclein is the culprit in Parkinson's disease. Neuron 40 2003 3 453 456
2. K K Dev K Hofele S Barbieri V L Buchman H Van der Putten p_herman.van_der_putten@pharma.novartis.com Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease. Neuropharmacology 45 2003 1 14 44
3. S Chandra G Gallardo R Fernandez-Chacon O M Schluter T C Sudhof thomas.sudhof@utsouthwestern.edu α-synuclein cooperates with CSPα in preventing neurodegeneration. Cell 123 2005 3 383 396 16269331
4. E Munoz R Oliva V Obach Identification of Spanish familial Parkinson's disease and screening for the Ala53Thr mutation of the α-synuclein gene in early onset patients. Neuroscience Letters 235 1997 1-2 57 60 9389595
5. R Kruger W Kuhn T Muller Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nature Genetics 18 1998 2 106 108 9462735
6. J J Zarranz jjzarranz@hcru.osakidetza.net J Alegre J C Gomez-Esteban The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Annals of Neurology 55 2004 2 164 173 14755719
7. M B Feany mel_feany@hms.harvard.edu W W Bender A Drosophila model of Parkinson's disease. Nature 404 2000 6776 394 398 10746727
8. J L Eriksen Z Wszolek L Petrucelli Molecular pathogenesis of Parkinson disease. Archives of Neurology 62 2005 3 353 357 15767499
9. M Matsuzaki T Hasegawa A Takeda Histochemical features of stress-induced aggregates in α-synuclein overexpressing cells. Brain Research 1004 2004 1-2 83 90 15033422
10. T Hasegawa M Matsuzaki A Takeda Accelerated α-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells. Brain Research 1013 2004 1 51 59 15196967
11. B I Giasson J E Duda I V Murray Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions. Science 290 2000 5493 985 989 11062131
12. S R Paik srpaik@dragon.inha.ac.kr H J Shin J H Lee Metal-catalyzed oxidation of α-synuclein in the presence of Copper(II) and hydrogen peroxide. Archives of Biochemistry and Biophysics 378 2000 2 269 277 10860544
13. E Paxinou Q Chen M Weisse Induction of α-synuclein aggregation by intracellular nitrative insult. The Journal of Neuroscience 21 2001 20 8053 8061 11588178
14. V N Uversky J Li A L Fink Evidence for a partially folded intermediate in α-synuclein fibril formation. The Journal of Biological Chemistry 276 2001 14 10737 10744 11152691
15. A Kikuchi A Takeda H Onodera Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy. Neurobiology of Disease 9 2002 2 244 248 11895375
16. J A Johnston C L Ward R R Kopito Aggresomes: a cellular response to misfolded proteins. The Journal of Cell Biology 143 1998 7 1883 1898 9864362
17. M Tanaka Y M Kim G Lee E Junn T Iwatsubo M M Mouradian Aggresomes formed by α-synuclein and synphilin-1 are cytoprotective. The Journal of Biological Chemistry 279 2004 6 4625 4631 14627698
18. M Arrasate S Mitra E S Schweitzer M R Segal S Finkbeiner Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431 2004 7010 805 810
19. M Matsuzaki-Kobayashi T Hasegawa A Kikuchi A Takeda Y Itoyama Role of iron in the intracellular aggregation of α-synuclein. Movement Disorders 19 2004 sup9 S36
20. H G Lee R B Petersen X Zhu Will preventing protein aggregates live up to its promise as prophylaxis against neurodegenerative diseases? Brain Pathology 13 2003 4 630 638
21. S Ueda shu-ueda@dokkyomed.ac.jp S Sakakibara E Watanabe K Yoshimoto N Koibuchi Vulnerability of monoaminergic neurons in the brainstem of the zitter rat in oxidative stress. Progress in Brain Research 136 2002 293 302
22. A H Stokes T G Hastings K E Vrana kvrana@wfubmc.edu Cytotoxic and genotoxic potential of dopamine. Journal of Neuroscience Research 55 1999 6 659 665
23. J L Bolton M A Trush T M Penning G Dryhurst T J Monks Role of quinones in toxicology. Chemical Research in Toxicology 13 2000 3 135 160
24. R G Perez J C Waymire E Lin J J Liu F Guo M J Zigmond A role for α-synuclein in the regulation of dopamine biosynthesis. The Journal of Neuroscience 22 2002 8 3090 3099
25. F J Lee f.lee@utoronto.ca F Liu Z B Pristupa H B Niznik Direct binding and functional coupling of α-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. FASEB Journal 15 2001 6 916 926
26. R G Perez perezrg@pitt.edu T G Hastings Could a loss of α-synuclein function put dopaminergic neurons at risk? Journal of Neurochemistry 89 2004 6 1318 1324 15189334
27. A Sidhu sidhua@georgetown.edu C Wersinger P Vernier α-synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease. FEBS Letters 565 2004 1-3 1 5
28. K A Conway J C Rochet R M Bieganski P T Jr Lansbury Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct. Science 294 2001 5545 1346 1349
29. H T Li D H Lin X Y Luo Inhibition of α-synuclein fibrillization by dopamine analogs via reaction with the amino groups of α-synuclein: implication for dopaminergic neurodegeneration. FEBS Journal 272 2005 14 3661 3672
30. A Takeda Y Tomita S Okinaga H Tagami S Shibahara Functional analysis of the cDNA encoding human tyrosinase precursor. Biochemical and Biophysical Research Communications 162 1989 3 984 990
31. T Hasegawa M Matsuzaki A Takeda Increased dopamine and its metabolites in SH-SY5Y neuroblastoma cells that express tyrosinase. Journal of Neurochemistry 87 2003 2 470 475
32. T Hasegawa M Matsuzaki-Kobayashi A Takeda Synergistic interaction between α-synuclein and oxidized catechol metabolites produced by tyrosinase: implications for selective neurodegeneration in Parkinson's disease. FEBS Letters 580 2006 2147 2152
33. H A Lashuel D Hartley B M Petre T Walz P T Jr Lansbury plansbury@rics.bwh.harvard.edu Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418 2002 6895 291
34. M J Volles P T Jr Lansbury Vesicle permeabilization by protofibrillar α-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry 41 2002 14 4595 4602
35. R Kayed Y Sokolov B Edmonds Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. The Journal of Biological Chemistry 279 2004 45 46363 46366
36. M R Gluck G D Zeevalk zeevalgd@umdnj.edu Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases. Journal of Neurochemistry 91 2004 4 788 795
37. K Furukawa M Matsuzaki-Kobayashi T Hasegawa High ion permeability of plasma membrane caused by the α-synuclein mutations contributes to cellular degeneration. Journal of Neurochemistry 97 2006 1071 1077
38. M P Mattson S L Chan Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits. Journal of Molecular Neuroscience 17 2001 2 205 224
39. K Furukawa furukawaka@grc.nia.nih.gov Y Wang P J Yao Alteration in calcium channel properties is responsible for the neurotoxic action of a familial frontotemporal dementia tau mutation. Journal of Neurochemistry 87 2003 2 427 436